Abern M - Search Results

1

Urology Residents' Experience and Attitude Toward Surgical Simulation: Presenting our 4-Year Experience With a Multi-institutional, Multi-modality Simulation Model.

Chow AK, Sherer BA, Yura E, Kielb S, Kocjancic E, Eggener S, Turk T, Park S, Psutka S, Abern M, Latchamsetty KC, Coogan CL. Chow AK, et al. Among authors: abern m. Urology. 2017 Nov;109:32-37. doi: 10.1016/j.urology.2017.05.037. Epub 2017 Aug 8. Urology. 2017. PMID: 28801218

2

Marital status independently predicts testis cancer survival--an analysis of the SEER database.

Abern MR, Dude AM, Coogan CL. Abern MR, et al. Urol Oncol. 2012 Jul-Aug;30(4):487-93. doi: 10.1016/j.urolonc.2010.03.005. Epub 2010 Sep 26. Urol Oncol. 2012. PMID: 20870430

3

An update on TroVax for the treatment of progressive castration-resistant prostate cancer.

Abern M, Kaufman HL, Latchamsetty K. Abern M, et al. Onco Targets Ther. 2011;4:33-41. doi: 10.2147/OTT.S14271. Epub 2011 May 24. Onco Targets Ther. 2011. PMID: 21691576 Free PMC article.

4

The characteristics of bladder cancer after radiotherapy for prostate cancer.

Abern MR, Dude AM, Tsivian M, Coogan CL. Abern MR, et al. Urol Oncol. 2013 Nov;31(8):1628-34. doi: 10.1016/j.urolonc.2012.04.006. Epub 2012 May 9. Urol Oncol. 2013. PMID: 22575239

5

Characteristics and outcomes of tumors arising from the distal nephron.

Abern MR, Tsivian M, Polascik TJ, Coogan CL. Abern MR, et al. Urology. 2012 Jul;80(1):140-6. doi: 10.1016/j.urology.2012.03.034. Epub 2012 May 23. Urology. 2012. PMID: 22626576

6

Characteristics of patients diagnosed with both melanoma and renal cell cancer.

Abern MR, Tsivian M, Coogan CL, Kaufman HL, Polascik TJ. Abern MR, et al. Cancer Causes Control. 2013 Nov;24(11):1925-33. doi: 10.1007/s10552-013-0267-0. Epub 2013 Jul 30. Cancer Causes Control. 2013. PMID: 23897487

7

Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.

Papagiannopoulos D, Abern M, Wilson N, O'Block N, Raff L, Coogan C, Latchamsetty KC. Papagiannopoulos D, et al. Among authors: abern m. J Urol. 2018 Jan;199(1):155-160. doi: 10.1016/j.juro.2017.08.040. Epub 2017 Aug 12. J Urol. 2018. PMID: 28807644

8

Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.

Tan WP, Papagiannopoulos D, Latchamsetty KC, Wilson N, O'Block N, Raff L, Mena Lora A, Coogan CL, Abern MR. Tan WP, et al. Prostate Cancer Prostatic Dis. 2019 May;22(2):268-275. doi: 10.1038/s41391-018-0092-3. Epub 2018 Oct 2. Prostate Cancer Prostatic Dis. 2019. PMID: 30279581

9

Constructing and Pilot Testing a Novel Prostate Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Phantom.

Caldwell B, Greenwald D, Moreira D, Tain RW, Coogan C, Xie K, Mar W, Pfanner P, Abern M. Caldwell B, et al. Among authors: abern m. Urology. 2019 Feb;124:33-37. doi: 10.1016/j.urology.2018.10.029. Epub 2018 Oct 24. Urology. 2019. PMID: 30366044

10

Correction: Predictors of fluoroquinolone-resistant bacteria in the rectal vault of men undergoing prostate biopsy.

Tan WP, Papagiannopoulos D, Latchamsetty KC, Wilson N, O'Block N, Raff L, Lora AM, Coogan CL, Abern MR. Tan WP, et al. Prostate Cancer Prostatic Dis. 2019 May;22(2):350. doi: 10.1038/s41391-019-0133-6. Prostate Cancer Prostatic Dis. 2019. PMID: 30705341

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters